Trial Site Detail
Drug: |
Dasatinib (BMS-354825) |
|||
|---|---|---|---|---|
Trial: |
Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Universitatsklinikum Essen, West Germany Cancer CenterHufelandstr. 55 |
Principal Investigator: |
|
|---|---|
Contact: |
49-201-723-85-011 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Universitatsklinikum Essen, West Germany Cancer Center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.